Recent 8-K filings for UHT
Highest-materiality recent filing
UHT Q4 net income $4.7M ($0.34/dil) up from $3.6M; FFO $11.8M ($0.85/dil)
- Net income Q4 2024: $4.7M ($0.34/dil) vs $3.6M ($0.26/dil) in Q4 2023; full year $19.2M ($1.39/dil) vs $15.4M ($1.11/dil).
- FFO Q4: $11.8M ($0.85/dil) vs $11.4M ($0.82/dil); full year FFO $47.9M ($3.46/dil) vs $44.6M ($3.23/dil).
-
UHT Q1 2026 EPS $0.36, FFO $0.88; credit line upsized to $475M
Net income $5.0M ($0.36/shr) vs $4.8M ($0.34/shr) in Q1 2025, up $0.02.
-
UHT enters $50M incremental term loan amendment; minimum tangible net worth set at $100M
New $50M incremental term loan under existing credit facility; matures Sept 30, 2028.
-
UHT Q4 net income $4.3M ($0.31 EPS), down YoY; FFO flat $0.85/share; new $34M MOB development
Q4 net income $4.3M ($0.31 diluted) vs $4.7M ($0.34) a year ago; FY 2025 net income $17.6M ($1.27) vs $19.2M ($1.39).
-
UHT reports Q3 net income of $0.29/sh; FFO $0.88/sh; announces $34M MOB development
Q3 net income $4.0M ($0.29/sh) flat YoY; FFO rose to $12.2M ($0.88/sh) from $11.3M ($0.82/sh).
-
UHT Q2 net income down to $4.5M ($0.32/sh); FFO per share $0.85 vs $0.90 YoY
Net income $4.5M, EPS $0.32 versus $5.3M ($0.38) in Q2 2024, down $784K.
-
UHT grants restricted stock to CEO Miller and other execs; annual meeting re-elects trustees
CEO Miller received 6,021 restricted shares; CFO Boyle and VP Ramagano each 3,499; VP Peterson 1,540.
-
Universal Health Realty Income Trust Q1 EPS $0.34 vs $0.38; FFO $0.86 vs $0.90
Q1 2025 net income $4.8M ($0.34 diluted EPS) down from $5.3M ($0.38) in Q1 2024.
-
UHT Q4 net income $4.7M ($0.34/dil) up from $3.6M; FFO $11.8M ($0.85/dil)
Net income Q4 2024: $4.7M ($0.34/dil) vs $3.6M ($0.26/dil) in Q4 2023; full year $19.2M ($1.39/dil) vs $15.4M ($1.11/dil).
-
UHT Q3 net income $4.0M ($0.29 EPS) vs $3.9M ($0.28); FFO $0.82
Net income $4.0M ($0.29 diluted EPS) vs $3.9M ($0.28) in Q3 2023; FFO $11.3M ($0.82) vs $11.2M ($0.81).
-
UHT enters $425M credit facility ($300M revolver + $125M term loan) maturing Sept 2028
New Second Amended and Restated Credit Agreement increases total commitments to $425M from prior $300M revolver.
-
UHT Q2 2024 net income $0.38/share, up 52% YoY; FFO $0.90/share vs $0.77
Q2 net income $5.3M ($0.38/diluted) vs $3.5M ($0.25) in Q2 2023; FFO $12.4M ($0.90) vs $10.6M ($0.77).
-
UHT shareholders re-elect trustees, approve pay votes and stock plan amendment
Elected Marc D. Miller (7.79M for) and Gayle L. Capozzalo (8.08M for) as Class II trustees for three-year terms.
-
UHT Q1 2024 net income $5.3M ($0.38/sh), FFO $12.4M ($0.90/sh), dividend $0.725/sh
Net income $5.3M ($0.38 diluted EPS) vs $4.5M ($0.32) in Q1 2023, up $0.06/sh.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.75 · Median 0.55 · Most common event earnings